Navigating the Diagnosis: Scans and Genetic Tests

Because BCAP31-related syndrome is so rare, reaching a diagnosis often feels like solving a complex puzzle. Doctors use two primary tools to put the pieces together: Neuroimaging (MRI) to see the brain’s structure and Genetic Testing to find the underlying cause at the cellular level.

Visualizing the Brain: MRI Findings

A brain MRI (Magnetic Resonance Imaging) uses powerful magnets to create detailed pictures. In children with DDCH, these scans often reveal a pattern that points toward the diagnosis, though no single finding is exclusive to this syndrome and MRI findings are supportive, not definitive on their own ^[1].

• Hypomyelination vs. Delayed Myelination: A single scan showing age-inappropriate myelin may represent delayed myelination. True hypomyelination generally requires age-appropriate neuroradiologic interpretation and often a follow-up scan showing a persistent pattern ^[2]. On an MRI, the brain may look like that of a much younger infant ^[1][2].
• Thin Corpus Callosum: The corpus callosum is the thick band of nerve fibers that connects the left and right sides of the brain. In many children with DDCH, this band is noticeably thinner than usual ^[1].
• White Matter Atrophy: This refers to a loss or shrinking of the brain’s white matter over time ^[1].
• Basal Ganglia Changes: In some infants, the MRI may show unusual signals in a part of the brain called the globus pallidus ^[3]. Because this same pattern is seen in mitochondrial diseases, it sometimes leads to an initial misdiagnosis before genetic results are back ^[3].

Decoding the Genetic Report

The definitive “answer” usually comes from a genetic test. When you look at the report, you may see terms that describe the specific “flavor” of the mutation:

• Loss-of-Function (LoF): These variants (which include “frameshift,” “nonsense,” or “splice-site” mutations) essentially stop the gene from working at all ^[2]. In boys, these are frequently reported with classic, severe symptoms of DDCH ^[2][4].
• Missense: This is a “spelling error” where one amino acid is swapped for another. These can be trickier to interpret; some are harmless, while others may cause a milder version of the syndrome ^[2][5].
• X-Linked Inheritance: Because the BCAP31 gene is on the X chromosome, boys (who have one X) are usually more severely affected than girls (who have two X’s) ^[1].
• De Novo vs. Inherited: A de novo variant is a “new” change that happened for the first time in the child and was not passed down from a parent ^[6]. An inherited variant was passed from a parent (usually the mother), who may or may not have mild symptoms like minor hearing loss ^[1][2].

Diagnostic Completeness Checklist

If your child is suspected of having BCAP31-related syndrome, a complete evaluation should include more than just a single test. Ensure your care team has covered these areas:

1. Genetic Confirmation: A report showing a “pathogenic” or “likely pathogenic” variant in the BCAP31 gene ^[6]. Note that whole-exome sequencing (WES) can miss copy-number changes, while a chromosomal microarray (CMA) can miss small sequence variants, so your team will choose the appropriate combination ^[6].
2. Parental Testing: To help interpret variants of uncertain significance and assess inheritance.
3. Liver Enzyme Panel: Blood tests to check AST and ALT levels, which are often elevated in this syndrome ^[2][4].
4. Audiology Assessment: A formal hearing test to identify the degree of sensorineural hearing loss ^[1][6].
5. Neurological Exam: An evaluation of muscle tone (hypotonia) and involuntary movements (dystonia) ^[3].
6. VLCFA Testing: If a large deletion is suspected (CADDS), a test for Very-Long-Chain Fatty Acids assesses the biochemical consequence of the neighboring ABCD1 gene involvement, though genetic testing is what proves the deletion ^[7].